MARKET

CSCI

CSCI

Cosciens Biopharma
NASDAQ
3.135
-0.085
-2.64%
After Hours: 3.210 +0.075 +2.39% 16:05 04/28 EDT
OPEN
3.160
PREV CLOSE
3.220
HIGH
3.160
LOW
3.135
VOLUME
1.01K
TURNOVER
0
52 WEEK HIGH
11.10
52 WEEK LOW
1.960
MARKET CAP
9.86M
P/E (TTM)
-0.5286
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CSCI last week (0414-0418)?
Weekly Report · 04/21 11:00
COSCIENS Biopharma Appoints Anna Biehn as New CEO to Drive Growth in Natural-Based Products
TipRanks · 04/14 11:48
Cosciens Biopharma Names Anna Biehn as Chief Executive
Dow Jones · 04/14 11:26
Cosciens Biopharma appoints Biehn as CEO
TipRanks · 04/14 11:16
*COSCIENS Biopharma: Current Pres and CEO Gilles Gagnon to Remain as a Strategic Adviser, Director >CSCI
Dow Jones · 04/14 11:01
*COSCIENS Biopharma Appoints Anna Biehn as CEO >CSCI
Dow Jones · 04/14 11:01
COSCIENS BIOPHARMA INC. APPOINTS GLOBAL CONSUMER PRODUCTS AND BIOSCIENCES EXECUTIVE, ANNA BIEHN AS CHIEF EXECUTIVE OFFICER
Reuters · 04/14 11:00
COSCIENS BIOPHARMA INC - APPOINTS ANNA BIEHN AS CEO EFFECTIVE MAY 5, 2025
Reuters · 04/14 11:00
More
About CSCI
More
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
Recently
Symbol
Price
%Change

Webull offers COSCIENS Biopharma Inc (USA) stock information, including NASDAQ: CSCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSCI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSCI stock methods without spending real money on the virtual paper trading platform.